Evidence map›Paper›PMID 29869155›Full record

ArticleEndocrine2018

High ApoD protein level in the round ligament fat depot of severely obese women is associated with an improved inflammatory profile.

Frederik Desmarais, Karl-F Bergeron, Michel Lacaille, Isabelle Lemieux, Jean Bergeron, Simon Biron, Eric Rassart, Denis R Joanisse, Pascale Mauriege, Catherine Mounier

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. ApoD mediates age-associated increase in vulnerability to influenza virus infection.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Apolipoprotein D in Oxidative Stress and Inflammation.Antioxidants (Basel, Switzerland) · 2023
    Review
  9. Apolipoprotein D modulates lipid mediators and osteopontin in an anti-inflammatory direction.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Apolipoprotein D.Gene · 2020
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Frederik DesmaraisBioMed Research Center, Department of Biological Sciences, University of Quebec in Montreal, Montreal, QC, Canada.
Karl-F BergeronBioMed Research Center, Department of Biological Sciences, University of Quebec in Montreal, Montreal, QC, Canada.
Michel LacailleDepartment of Kinesiology, Faculty of Medicine, Laval University, Quebec City, QC, Canada.
Isabelle LemieuxResearch Center of the Quebec University Heart and Lung Institute, Quebec City, QC, Canada.
Jean BergeronEndocrinology and Nephrology Axis, Research Center of the University Hospital, Quebec City, QC, Canada.
Simon BironResearch Center of the Quebec University Heart and Lung Institute, Quebec City, QC, Canada.
Eric RassartBioMed Research Center, Department of Biological Sciences, University of Quebec in Montreal, Montreal, QC, Canada.
Denis R JoanisseDepartment of Kinesiology, Faculty of Medicine, Laval University, Quebec City, QC, Canada.
Pascale MauriegeDepartment of Kinesiology, Faculty of Medicine, Laval University, Quebec City, QC, Canada.
Catherine MounierBioMed Research Center, Department of Biological Sciences, University of Quebec in Montreal, Montreal, QC, Canada. mounier.catherine@uqam.ca.
Université du Québec à Montréal · CAMontreal Heart Institute · CAUniversité Laval · CA

Funding

CIHR
6 · The paper itself

Abstract

purposeApolipoprotein D (ApoD) is a lipocalin participating in lipid transport. It binds to a variety of ligands, with a higher affinity for arachidonic acid, and is thought to have a diverse array of functions. We investigated a potential role for ApoD in insulin sensitivity, inflammation, and thrombosis-processes related to lipid metabolism-in severely obese women.

methodsWe measured ApoD expression in a cohort of 44 severely obese women including dysmetabolic and non-dysmetabolic patients. Physical and metabolic characteristics of these women were determined from anthropometric measurements and blood samples. ApoD was quantified at the mRNA and protein levels in samples from three intra-abdominal adipose tissues (AT): omental, mesenteric and round ligament (RL).

resultsApoD protein levels were highly variable between AT of the same individual. High ApoD protein levels, particularly in the RL depot, were linked to lower plasma insulin levels (-40%, p = 0.015) and insulin resistance (-47%, p = 0.022), and increased insulin sensitivity (+10%, p = 0.008). Lower circulating pro-inflammatory PAI-1 (-39%, p = 0.001), and TNF-α (-19%, p = 0.030) levels were also correlated to high ApoD protein in the RL AT.

conclusionsApoD variability between AT was consistent with different accumulation efficiencies and/or metabolic functions according to the anatomic location of fat depots. Most statistically significant correlations implicated ApoD protein levels, in agreement with protein accumulation in target tissues. These correlations associated higher ApoD levels in fat depots with improved metabolic health in severely obese women.

Indexed as

AdultApolipoproteins DFemaleHumansInflammationInflammation MediatorsInsulin ResistanceInterleukin-6Intra-Abdominal FatLipid MetabolismMiddle AgedObesity, MorbidPlasminogen Activator Inhibitor 1Round LigamentsTumor Necrosis Factor-alphaYoung AdultApolipoproteins DInflammation MediatorsInterleukin-6Plasminogen Activator Inhibitor 1Tumor Necrosis Factor-alphaApolipoprotein DInsulinObesityPlasminogen activator inhibitor-1Round ligamentTumor necrosis factor-α

Identifiers

PMID29869155
OpenAlexW2807030957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.